"10.1371_journal.pone.0064486","plos one","2013-05-14T00:00:00Z","Oleg F Sharifov; Xin Xu; Amit Gaggar; William E Grizzle; Vinod K Mishra; Jaideep Honavar; Silvio H Litovsky; Mayakonda N Palgunachari; C Roger White; G M Anantharamaiah; Himanshu Gupta","Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Medicine Service, United States Department of Veterans Affairs Medical Center, Birmingham, Alabama, United States of America; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Department of Medicine, Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America","Conceived and designed the experiments: OFS AG CRW GMA HG. Performed the experiments: OFS XX JH MNP. Analyzed the data: OFS XX WEG SHL VKM GMA HG. Contributed reagents/materials/analysis tools: MNP GMA. Wrote the paper: OFS AG VKM CRW GMA HG.","Dr. Amit Gaggar, the co-author of this manuscript, is a PLOS ONE Editorial Board member. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. Dr. G. M. Anantharamaiah, the co-investigator and co-author of this manuscript, is inventor of the peptide L-4F. Dr. G. M. Anantharamaiah is a principal in Bruin Pharma. He has several patents on apoA-I mimetic peptides. However, since he is involved in basic research using these peptides as tools to understand HDL structure and function, this does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Oleg F Sharifov","OFS",11,TRUE,5,4,7,6,TRUE,TRUE,FALSE,0,NA,FALSE
